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Enhanced Astrocytic Ca2+ Signals Contribute to Neuronal Excitotoxicity
after Status Epilepticus
Abstract
Status epilepticus (SE), an unremitting seizure, is known to cause a variety of traumatic responses including
delayed neuronal death and later cognitive decline. Although excitotoxicity has been implicated in this delayed
process, the cellular mechanisms are unclear. Because our previous brain slice studies have shown that
chemically induced epileptiform activity can lead to elevated astrocytic Ca2+ signaling and because these
signals are able to induce the release of the excitotoxic transmitter glutamate from these glia, we asked whether
astrocytes are activated during status epilepticus and whether they contribute to delayed neuronal death in
vivo. Using two-photon microscopy in vivo, we show that status epilepticus enhances astrocytic Ca2+ signals
for 3 d and that the period of elevated glial Ca2+ signaling is correlated with the period of delayed neuronal
death. To ask whether astrocytes contribute to delayed neuronal death, we first administered antagonists
which inhibit gliotransmission: MPEP [2-methyl-6-(phenylethynyl)pyridine], a metabotropic glutamate
receptor 5 antagonist that blocks astrocytic Ca2+ signals in vivo, and ifenprodil, an NMDA receptor antagonist
that reduces the actions of glial-derived glutamate. Administration of these antagonists after SE provided
significant neuronal protection raising the potential for a glial contribution to neuronal death. To test this glial
hypothesis directly, we loaded Ca2+ chelators selectively into astrocytes after status epilepticus.We
demonstrate that the selective attenuation of glial Ca2+ signals leads to neuronal protection. These
observations support neurotoxic roles for astrocytic gliotransmission in pathological conditions and identify
this process as a novel therapeutic target.
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Neurobiology of Disease
Enhanced Astrocytic Ca2 Signals Contribute to Neuronal
Excitotoxicity after Status Epilepticus
Shinghua Ding,1* Tommaso Fellin,1* Yingzi Zhu,1* So-Young Lee,1 Yves P. Auberson,4 David F. Meaney,2
Douglas A. Coulter,1,3 Giorgio Carmignoto,5 and Philip G. Haydon1
1Silvio Conte Center for Integration at the Tripartite Synapse, Department of Neuroscience, University of Pennsylvania School of Medicine, 2Department of
Bioengineering, University of Pennsylvania, and 3Departments of Pediatrics and Neurology, University of Pennsylvania School of Medicine and the
Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania 19104, 4Novartis Institutes for BioMedical Research, Novartis Pharma AG, 4002 Basel,
Switzerland, and 5Instituto Consiglio Nazionale delle Ricerche di Neuroscienze and Dipartimento di Scienze Biomediche Sperimentali, Università di
Padova, 35121 Padova, Italy
Status epilepticus (SE), an unremitting seizure, is known to cause a variety of traumatic responses including delayed neuronal death and
later cognitive decline. Although excitotoxicity has been implicated in this delayed process, the cellular mechanisms are unclear. Because
our previous brain slice studies have shown that chemically induced epileptiform activity can lead to elevated astrocytic Ca 2 signaling
and because these signals are able to induce the release of the excitotoxic transmitter glutamate from these glia, we asked whether
astrocytes are activated during status epilepticus and whether they contribute to delayed neuronal death in vivo. Using two-photon
microscopy in vivo, we show that status epilepticus enhances astrocytic Ca 2 signals for 3 d and that the period of elevated glial Ca 2
signaling is correlated with the period of delayed neuronal death. To ask whether astrocytes contribute to delayed neuronal death, we first
administered antagonists which inhibit gliotransmission: MPEP [2-methyl-6-(phenylethynyl)pyridine], a metabotropic glutamate re-
ceptor 5 antagonist that blocks astrocytic Ca 2 signals in vivo, and ifenprodil, an NMDA receptor antagonist that reduces the actions of
glial-derived glutamate. Administration of these antagonists after SE provided significant neuronal protection raising the potential for a
glial contribution to neuronal death. To test this glial hypothesis directly, we loaded Ca 2 chelators selectively into astrocytes after status
epilepticus. We demonstrate that the selective attenuation of glial Ca 2 signals leads to neuronal protection. These observations support
neurotoxic roles for astrocytic gliotransmission in pathological conditions and identify this process as a novel therapeutic target.
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Introduction
Traumatic head injury, stroke, or status epilepticus (SE) lead to
the delayed death of neurons, which results in cognitive decline
and later to epilepsy (Lemos and Cavalheiro, 1995). The cellular
changes after the injury that lead to the delayed neuronal death
are poorly defined. One of the precipitating injuries, SE, stimu-
lates neuronal death lasting for days after the episode as well as the
birth of new neurons, axon collateral sprouting, synaptogenesis,
and reactive astrocytosis (Babb et al., 1984, 1991; de Lanerolle et
al., 1989; Sutula et al., 1989; Houser, 1992, 1999; Houser et al.,
1992; Houser and Esclapez, 1996; Fonseca et al., 2002; Garzillo
and Mello, 2002). Because reactive astrocytes are associated with
many disorders of the nervous system (Miller, 2005), we have
become particularly interested in the potential role of astrocytes
in delayed responses to injury.
Recent studies have demonstrated that astrocytes can release
chemical transmitters, including glutamate and D-serine, which
can regulate synaptic transmission and neuronal excitability
through the activation of extrasynaptic NR2B-containing
NMDA receptors (Araque et al., 2001; Haydon, 2001; Newman,
2003; Fellin et al., 2004). In addition to playing roles in physiol-
ogy, this glial source of glutamate/D-serine has the potential to
cause neuronal excitotoxicity because the activation of extrasyn-
aptic NMDA receptors as well as NR2B-containing NMDA re-
ceptors has been shown to activate the neuronal cell death path-
way (Hardingham et al., 2002; Zeron et al., 2002; Deridder et al.,
2005; Gao et al., 2005).
Previous brain slice studies have shown that chemically in-
duced epileptiform activity causes a sustained increase in Ca 2
signaling (Tian et al., 2005; Fellin et al., 2006) within astrocytes
that outlasts the period of neuronal activity (Fellin et al., 2006).
Because this prolonged elevation of glial Ca 2 signaling induces
the release of glutamate, it has the potential to provide a sustained
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activation of NMDA receptors and possibly excitotoxicity. In this
study, we focused our investigation in vivo where we asked
whether SE induces astrocytic Ca 2 signals, and whether as a
consequence the release of gliotransmitters could contribute to
the delayed neuronal death that follows SE. We show that
pilocarpine-induced SE stimulates a hyperactivation of the astro-
cyte by initiating Ca 2 signals that last for 3 d. Using pharmaco-
logical approaches that impact NMDA receptor-mediated glio-
transmission, but not synaptic transmission, we demonstrate
neuroprotection, allowing us to hypothesize that these glial Ca 2
signals initiate delayed neuronal death through activation of ex-
trasynaptic NMDA receptors. To test this notion, we then atten-
uate Ca 2 signals in these glial cells in vivo using two independent
Ca 2 buffers and demonstrate that astrocytic Ca 2 signaling,
and thus Ca 2-dependent gliotransmission, contributes signifi-
cantly to delayed neuronal death. This study provides new in-
sights into pathological roles of astrocytes, implicating them as a
critical signaling element that contributes in the induction of
neuronal death.
Materials and Methods
All procedures were in strict accordance with the National Institutes of
Health Guide for the Care and Use of Laboratory Animals and were ap-
proved by the University of Pennsylvania Institutional Animal Care and
Use Committee.
Slice preparation, patch-clamp recordings, and analysis. Transverse
brain slices (300 – 400 m) were prepared from FVB/NJ mice (The Jack-
son Laboratory, Bar Harbor, ME) at postnatal days 12– 45 as described
previously (Pasti et al., 1997). After preparation, slices were incubated at
37°C for a recovery period of 1 h. The solution for slice cutting and
incubation was as follows (in mM): 120 NaCl, 3.2 KCl, 1 NaH2PO4, 26
NaHCO3, 2 MgCl2, 1 CaCl2, 2.8 glucose, 2 Na-pyruvate, and 0.6 ascorbic
acid at pH 7.4 with 95% O2 and 5% CO2. In the recording chamber, slices
were continuously perfused with normal artificial CSF (ACSF) (in mM):
120 NaCl, 3.2 KCl, 1 NaH2PO4, 26 NaHCO3, 1 MgCl2, 2 CaCl2, 2.8
glucose, at pH 7.4 with 95% O2 and 5% CO2. Low Ca
2 solution was
obtained by replacing CaCl2 with EGTA (0.25 mM). To elicit persistent
epileptiform activity, in the experiments in Figure 4, J and K, pilocarpine
was applied together with an additional epileptogenic stimulus as done
previously (Rutecki and Yang, 1998). In this case, pilocarpine was per-
fused in 0 Mg 2-containing ACSF and in the presence of picrotoxin (100
M). Pipette resistance was 3– 4 M. Intrapipette solution was as follows
(in mM): 145 K-gluconate, 2 MgCl2, 5 EGTA, 2 Na2ATP, 0.2 NaGTP, 10
HEPES to pH 7.2 with KOH. Patch-clamp recordings were performed
from layer 2/3 cortical neurons using standard procedures and
MultiClamp-700B amplifiers (Molecular Devices, Union City, CA) or
2400 patch-clamp amplifiers (A-M Systems, Sequim, WA). Data were
filtered at 1 kHz and sampled at 5 kHz with a Digidata 1320 interface and
pClamp software (Molecular Devices). Experiments were performed at
30 –35°C. Layer 2/3 pyramidal neurons were voltage-clamped at 60
mV. Evoked postsynaptic currents (EPSCs) were elicited by intracortical
stimulation (0.1 Hz) with a bipolar tungsten electrode placed 100 –200
m beneath the recording pipette (approximately layer IV). The rise
time of the NMDA component of the EPSCs and slow inward currents
(SICs) was calculated with the 20 – 80% criterion and the decay time as
the time constant of a single exponential fit. Extracellular field EPSPs
were recorded with normal ACSF in the pipette and stimulating intra-
cortical synapses as described previously for the patch-clamp recording.
Data were filtered at 4 kHz and sampled at 20 kHz. Data analysis and
fitting were performed with Clampfit 9.2 (Molecular Devices), Origin
(Microcal Software, Northampton, MA), and SigmaPlot 8.0 (SPSS, Chi-
cago, IL) software.
Photolysis. Transverse brain slices were obtained from 10- to 16-d-old
C57BL/6 (The Jackson Laboratory). After preparation, slices were incu-
bated at 33–35°C for a recovery period of 30 – 40 min. Slices were bulk
loaded for 1.5 h at room temperature in the cutting solution containing
fluo-4 AM (12.5 g/ml), NP-EGTA-AM (12.5 g/ml), and pluronic acid
(1 l/ml of 20% DMSO solution) saturated with 95% O2 and 5% CO2.
The internal solution contained the following (in mM): 135 K-gluconate,
2.7 MgCl2, 1.7 NaCl, 1.1 EGTA, 0.1 CaCl2, 3.5 MgATP, 0.3 NaGTP, and
10 HEPES to pH 7.25 with KOH. The fluorescent dye Alexa 568 (0.1 mM)
was added to internal solution to visualize the dendrites of the recorded
neuron. Neuronal currents were monitored for 6 min before and after
photolysis of one or two astrocytes that were close to neuronal dendrites,
and the average SIC frequency was calculated in these time periods. Pho-
torelease of Ca 2 was performed by a 3-m-diameter UV pulse (351 and
364 nm) generated by an argon ion laser (Coherent Enterprise II; 100 ms
duration for three times; power, 30 mW) connected by an optical fiber to
an Uncager system (Prairie Technologies, Middleton, WI). Images were
acquired using a Q-Imaging (Burnaby, British Columbia, Canada)
cooled CCD camera and ImagePro software.
Pilocarpine-induced SE. Male FVB/NJ mice (6 – 8 weeks old) from The
Jackson Laboratory were used in these experiments. Behavioral seizures
were assessed according to the scale of Racine (1972). Thirty minutes
before the injection of pilocarpine, methylscopolamine (a muscarinic
antagonist) was administered subcutaneously (1 mg/kg) to reduce ad-
verse, peripheral effects. SE was induced through subcutaneous injection
of 350 mg/kg pilocarpine-hydrochloride, a muscarinic agonist. Animal
behavior and seizure activity was documented throughout the proce-
dure. One hour after the onset of SE, diazepam (5 mg/ml) was adminis-
tered subcutaneously to reduce seizure activity. Two groups of control
mice were used, either those injected with saline or with a one-tenth dose
of pilocarpine. For experiments in which we pharmacologically manip-
ulated gliotransmission after SE, 2-methyl-6-(phenylethynyl)pyridine
(MPEP) and ifenprodil (20 mg/kg), or [( R)-[( S)-1-(4-bromo-phenyl)
ethylamino]-(2,3-dioxo-1,2,3,4- tetrahydro-quinoxalin-5-yl)methyl]
phosphonic acid (NVP-AAM077) (2 mg/kg) were administered intra-
peritoneally to mice together with diazepam. ()-5-Methyl-10,11-
dihydro-SH-dibenzo[a,d]cyclohepten-5,10-imine maleate (MK-801) (1
mg/kg) was delivered 2 h after diazepam. Antagonists were subsequently
administered intraperitoneally once daily for up to 3 d before killing. For
experiments in which we selectively attenuate astrocytic calcium signal
after SE, animals were anesthetized 4 –5 h after the onset of SE using
xylazine/ketamine. A craniotomy was made on one side of cortex and
either BAPTA-AM (200 M) or fluo-4 AM (500 M) was locally applied
to the cortical surface through the craniotomy. The cortex was then
covered with 2% agarose containing either BAPTA-AM or fluo-4 AM,
the incision was closed, and animals were allowed to recover, returned to
the animal facility, and then killed 3 d later for Fluoro-Jade B (FJB)
staining.
In vivo two-photon Ca2 imaging. Six- to 8-week-old FVB/NJ mice
were anesthetized with urethane (1.5–2.0 mg/g body weight), held in a
custom-made immobilization device, and a circular cranial window (2.0
mm diameter) was drilled in the skull overlying the barrel cortex. A metal
frame, to attach the skull to the microscope platform, was attached to the
skull using cyanoacrylate, and the dura was carefully removed. Two mi-
croliters of 50 g of fluo-4 AM mixed with 5 l of pluronic (20% plu-
ronic plus 80% DMSO) was mixed with 30 l of ACSF [containing the
following (in mM): 120 NaCl, 10 HEPES, 3 KCl, 2 CaCl2, 1 MgCl2, 10
glucose; with pH 7.4] and was applied through the cranial window to the
surface of the cortex. After 45– 60 min, excess dye was removed by irri-
gation with ACSF. As described (Hirase et al., 2004; Nimmerjahn et al.,
2004), this protocol leads to the selective labeling of astrocytes with the
Ca 2 indicator, fluo-4. In some experiments, selectivity of labeling was
confirmed using sulforhodamine 101 (SR101) (supplemental Fig. 4,
available at www.jneurosci.org as supplemental material). One hundred
microliters of 100 M SR101 dissolved in ACSF was applied on the sur-
face of the cranial window for 1–5 min before being washed away with
ACSF. After 45– 60 min, astrocytes were labeled selectively with SR101.
Using two wide-field detectors, we confirmed colabeling of astrocytes
with fluo-4 and SR101. To reduce movement artifacts, a glass coverslip
was glued over the cranial window on the metal frame, and the gap
between glass and cranial window was filled with 2% agarose premelted
in ACSF solution.
After dye loading, mice were transferred to the microscope stage and
were placed on a heating pad to keep the mice warmed at 37°C. In vivo
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two-photon imaging was performed using a Prairie Technologies
(Middleton, WI) Ultima two-photon microscope attached to an Olym-
pus (Tokyo, Japan) BX51 microscope equipped with a 60 water-
immersion objective. A Chameleon Titanium:Sapphire laser (Coherent,
Santa Clara, CA) was used for two-photon excitation. Excitation was
provided at 820 nm and emission was detected by external photomulti-
plier tubes (525/70; DLCP 575; 607/45 nm). To reduce movement arti-
facts in each image, we sampled from a region of a full image and ac-
quired each frame at 3.2 s/pixel.
In some experiments, we coinjected MPEP together with the fluores-
cent dye rhodamine-dextran through the tail vein. A mixture of 200 l of
ACSF containing 10 mg/ml rhodamine-dextran and plus MPEP to yield
a final concentration of MPEP of 1 g/g was injected into the tail vein.
Successful injection was confirmed by the rapid appearance of rhoda-
mine in the vasculature within the cortex. We waited at least 30 min
before recommencing Ca 2 imaging to ensure that the MPEP had
crossed the blood– brain barrier. To study acute the effects of ifenprodil,
3,5-dihydroxyphenylglycine (DHPG), or 2-chloro-5-hydroxyphenylglycine
(CHPG) on the Ca 2 signals, these drugs were applied to the cortical
surface for 30 min before recommencing imaging. The cranial window
was then refilled with 2% agarose containing the same concentration of
drug.
The fluorescent signals were quantified by measuring the mean pixel
intensities of the region of interest using MetaMorph software (Universal
Imaging, West Chester, PA). Ca 2 changes were expressed as F/F0
values, where F0 was the baseline fluorescence. To express the magnitude
of Ca 2 signals without subjective selection of threshold values, we inte-
grated the F/F0 signal over a 300 s imaging period using Origin software.
The resulting value is expressed as F/F0  s in all graphs.
We recorded whisker-evoked potentials (EPs) using a glass electrode
filled with ACSF and connected to a Swam IIC amplifier (Celica,
Ljubljana, Slovenia). We stimulated mouse whiskers with a 100 ms air
puff through a glass tube while the EP was being recorded. Data were
acquired with a Digidata 1320 interface and pClamp software (Molecular
Devices).
Transcardial perfusion and immunocytochemistry staining. Mice were
anesthetized with halothane and transcardially perfused first with ice-
cold PBS and then 4% paraformadehyde in PBS (pH 7.4). After perfu-
sion, the brain was postfixed in 4% paraformadehyde/PBS at 4°C for 30
min. It then was transferred to 30% sucrose overnight to prevent ice
crystal formation. Coronal sections of the brain (20 m) were cut on a
cryostat (CM 3000; Leica, Nussloch, Germany), and were collected seri-
ally on precleaned slides and stored at 80°C until use. For Fluoro-Jade
B staining, sections were washed with PBS three times and then im-
mersed into 0.0001% Fluoro-Jade in 0.1% acetic acid solution at 4°C for
1 h. For double staining, sections were stained with either terminal de-
oxynucleotidyl transferase-mediated biotinylated UTP nick end labeling
staining kit (Upstate, Charlottesville, VA) or biotinylated mouse anti-
NeuN (1:100) followed by the FJB staining procedure as described above.
All sections were counterstained with 4,6-diamidino-2-phenylindole
(DAPI) (1:1000; in PBS) and mounted using anti-fade mounting me-
dium. Stained sections were viewed with epifluorescence and double-
stained sections were examined using an Olympus Fluoview 1000 confo-
cal microscope and analyzed using MetaMorph (Universal Imaging).
Four random sections were selected from every animal. The number of
FJB-labeled cells was counted bilaterally by a blinded investigator. To
count the number of neurons in area CA3 and cortex cells, images of
DAPI and NeuN staining in area CA3 of the hippocampus and 70 –150
m beneath the surface of cortex were acquired with a digital camera.
Automated software was used to identify and count neuronal cell bodies
based on the colocalization of NeuN with DAPI. Manual inspection con-
firmed the accuracy of this automated approach.
For studies of metabotropic glutamate receptor 5 (mGluR5) localiza-
tion, sections obtained from GFAP-green fluorescent protein (GFP)
transgenic mice (Zhuo et al., 1997) were cut (40 m) and kept at 20°C
in cryoprotective solution (30% sucrose, 30% ethylenglycol, 1% polyvi-
nylpyrrolidone in PBS) until processing. After washing with PBS, sec-
tions were incubated in blocking solution (2 h; 2% normal horse serum,
0.5% BSA, and 0.3% Triton X-100 in PBS) and subsequently in blocking
solution containing the primary antibody (rabbit anti-mGluR5; Chemi-
con International, Temecula, CA) for 48 h at 4°C. After washing in PBS,
sections were incubated in blocking solution containing biotinylated anti
rabbit antibody (2 h; room temperature), and then rinsed in PBS and
incubated for 15 min in PBS containing Texas Red Avidin DCS (Vector
Laboratories, Burlingame, CA). After being washed in PBS, sections were
mounted using Vectashield mounting medium (Vector Laboratories).
To study mGluR5 colocalization with astrocytes, we made an image mask
based on GFP fluorescence to exclude and set to an intensity value of 0
those pixels that did not colocalize (supplemental Fig. 1, available at
www.jneurosci.org as supplemental material).
Statistics. n values reported in in vivo studies represent the number of
animals. In our in vivo imaging experiments, Ca 2 measurements were
generally made from 6 –10 astrocytes per animal, and the data were av-
eraged to obtain a single value per animal. Similarly in neuron and FJB
counting studies, measurements were made on at least four sections,
which were used to obtain a single value representative of that animal.
When multiple comparisons were performed (for example, as shown in
Fig. 5 and supplemental Fig. 3, available at www.jneurosci.org as supple-
mental material), ANOVA tests were performed and differences between
individual groups were determined using the Newman–Keuls post hoc
tests. Electrophysiological studies were tested for significance using the
Student’s t test unless stated otherwise. Statistical significance of data was
reached at p  0.05.
Results
SE triggers delayed astrocytic Ca 2 signals in vivo during the
latent period of epileptogenesis
Chemically induced epileptiform activity in brain slice prepara-
tions (Tian et al., 2005; Fellin et al., 2006) or in vivo (Hirase et al.,
2004), in addition to evoking intense neuronal discharges, stim-
ulates astrocytic Ca 2 signals. We recently demonstrated that
chemically induced epileptiform activity induces a prolonged in-
crease in astrocytic Ca 2 excitability that outlasts the period of
epileptiform activity (Fellin et al., 2006), raising the potential for
the excitability of the astrocyte to be altered in a long-term man-
ner after seizure activity in vivo. We directly tested this hypothesis
by using two-photon imaging of astrocytic Ca 2 (Hirase et al.,
2004; Nimmerjahn et al., 2004) to ask whether seizures per se
persistently modify the excitability of astrocytes. Layer 2/3 astro-
cytes in the barrel cortex were selectively loaded with the Ca 2
indicator fluo-4 either before or 2 or more days after pilocarpine-
induced SE (Nimmerjahn et al., 2004). Intraperitoneal adminis-
tration of pilocarpine into anesthetized mice induced astrocytic
Ca 2 signals from a control value of 7.7  1.6 (F/F0  s) to
43.2  4.6 (n  6) that are synchronized among networks of
astrocytes (Fig. 1A,B) (n  6 mice; p  0.0001). To determine
whether this acute change in Ca 2 signal might persist, we in-
duced SE in mice and then imaged astrocytic Ca 2 2 or more days
later. Three days after SE, we observed a significant increase in
astrocytic Ca 2 signals in mice that had entered SE compared
with control mice that received either a saline injection or sub-
threshold injection of pilocarpine (Fig. 1C–E) ( p  0.001). This
prolonged enhancement of Ca 2 excitability was detected for 3 d
after SE, and then recovered to control levels thereafter (Fig. 1E).
mGluR5 mediates enhanced astrocytic calcium signals
after SE
Because metabotropic glutamate receptors, and mGluR5 in par-
ticular, contribute to astrocytic Ca 2 signals in brain slices (Pasti
et al., 1997; Parri et al., 2001; Bowser and Khakh, 2004; D’Ascenzo
et al., 2007), we asked whether mGluR5 mediates the enhanced
astrocytic Ca 2 signaling detected after SE. Anti-mGluR5 immu-
noreactivity showed colocalization with cortical astrocytes in
GFAP-GFP transgenic mice raising the potential for direct
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mGluR5-mediated control of astrocytic Ca 2 signals (supple-
mental Fig. 1A–C, available at www.jneurosci.org as supplemen-
tal material). We therefore determined whether mGluR5 has the
potential to stimulate astrocytic Ca 2 signals in vivo by local
application of mGluR5 agonists to the cortex of control mice.
Application of either DHPG (25 M), a class I mGluR agonist, or
CHPG (1 mM), a selective mGluR5 agonist, induced enhanced
Ca 2 signaling within astrocytes (Fig. 2). Ca 2 signals that initi-
ate within the processes of an astrocyte propagate through the cell
and couple to adjacent astrocytes in the form of a Ca 2 wave (Fig.
2A) (n  5 animals). CHPG-induced
Ca 2 signals are attributable to the selec-
tive activation of mGluR5 because they are
prevented by the mGluR5 antagonist
MPEP (30 M) (Fig. 2B,C). Because acti-
vation of mGluR5 does stimulate astro-
cytic Ca 2 signals, we determined whether
mGluR5 is responsible for the enhanced
astrocytic Ca 2 signals observed days after
SE. Three days after SE, we measured as-
trocytic Ca 2 signals, and then injected
the mGluR5 antagonist MPEP (1 mg/kg
weight) through the tail vein, together
with rhodamine-dextran as a positive label
for successful injection (Fig. 3A). MPEP,
which crosses the blood– brain barrier, sig-
nificantly reduced the astrocytic Ca 2 sig-
nals (Fig. 3B,C) (n  4 animals; p 
0.002). Because class I mGluR agonists/an-
tagonists had inconsistent effects on intra-
cortical synaptic transmission (supple-
mental Fig. 1D–G, available at www.
jneurosci.org as supplemental material)
yet reliably induce astrocytic Ca 2 signals
(Fig. 2), these results demonstrate the im-
portance of mGluR5 for the activation of
Ca 2 signals in astrocytes after SE.
mGluR5-dependent activation of
astrocytic Ca 2 signaling evokes NR2B-
dependent NMDA receptor-mediated
neuronal currents
Because of the potential for astrocytic
Ca 2 signals to cause glutamate-
mediated neuronal excitation, as has
been described for thalamic (Parri et al.,
2001), hippocampal pyramidal neurons
(Angulo et al., 2004; Fellin et al., 2004;
Kang et al., 2005; Perea and Araque,
2005), and medium spiny neurons of the
nucleus accumbens (D’Ascenzo et al.,
2007), we performed studies in acutely
isolated brain slices to determine
whether layer 2/3 cortical astrocytes ex-
cite cortical pyramidal neurons. Astro-
cytic Ca 2 signals evoked SICs mediated
by NMDA receptors that can be identi-
fied based on four properties (Parri et
al., 2001; Angulo et al., 2004; Fellin et al.,
2004; Perea and Araque, 2005): their
slow kinetics, their insensitivity to TTX
and 2,3-dioxo - 6 - nitro - 1,2,3,4 -
tetrahydrobenzoquinoxaline - 7 - sulfon-
amide (NBQX), and their blockade by D-AP5. The class I
mGluR agonist DHPG (10 –20 M) as well as the mGluR5
selective agonist CHPG (0.5–1 mM) induced TTX-insensitive
SICs in layer 2/3 cortical neurons that were blocked by the
mGluR5 antagonist MPEP (50 M) (Fig. 4 A, B) (n  17; p 
0.05). These slow currents share kinetics typical of previously
identified SICs (Fellin et al., 2004), which are one order of
magnitude slower than NMDA-mediated synaptic-evoked
currents (supplemental Table 1, available at www.
jneurosci.org as supplemental material). In addition to exhib-
Figure 1. SE stimulates astrocytic Ca 2 signals. A, B, The time course of somatic Ca 2 signals recorded simultaneously in four
astrocytes before (A) and after (B) acute injection of pilocarpine to the anesthetized mouse. Astrocytic Ca 2 signals (3 examples
from 3 mice in each condition) recorded 3 d after a subthreshold injection of pilocarpine (Control) (C) or 3 d after SE (D). E, Time
course of change in Ca 2 signals after SE reported as the integral of the F/F0 signal (*p  0.05; **p  0.00005; n value is
between 4 and 8 animals for each time point). Error bars indicate SEM.
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iting slow kinetics and an insensitivity to TTX, SICs fulfill the
remaining pharmacological criteria to assign their origin to
the astrocyte: they are mediated by the selective activation of
NMDA receptors (NMDARs) because they are reversibly
blocked by D-AP5 (50 M) (Fig. 4 D), whereas NBQX (10 M)
does not change the amplitude and kinetics of SICs (supple-
mental Table 1, available at www.jneurosci.org as supplemen-
tal material). To confirm the Ca 2 dependence of SICs, we
photoreleased Ca 2 from the Ca 2 cage NP-EGTA that had
been selectively loaded into astrocytes. Photolysis evoked a
transient elevation of Ca 2 with similar properties to astro-
cytic Ca 2 signals induced by SE (Fig. 1 B, D) that lasted for
7.5  1.8 s (full-width half-maximum duration; mean F/F0,
1.29  0.39) and evoked TTX-insensitive SICs in four of six
cortical pyramidal neurons tested (Fig. 4C). These results are
consistent with mGluR5 inducing astrocytic Ca 2 signals
Figure 2. mGluR5 stimulates astrocytic Ca 2 signals in vivo. A, SequentialF/F0 images showing that cortical astrocytes exhibit propagating Ca
2 waves in vivo when stimulated by the mGluR5
agonist CHPG (1 mM). B, Time courses of somatic Ca 2 fluorescence changes (F/F0; examples of 4 cells in each case) in control animals in the absence and presence CHPG (1 mM) as well as with CHPG
in the presence of MPEP (30 M) and ifenprodil (10 M). Note that the mGluR5 antagonist MPEP and not the NR2B NMDA receptor antagonist, ifenprodil, attenuate CHPG-induced Ca 2 signaling.
The boxed region corresponds to the images in A. C, Astrocytic Ca 2 signals are stimulated by DHPG (25 M) and CHPG (1 mM). The mGluR5 antagonist MPEP, but not the NR2B NMDA receptor
antagonist ifenprodil, significantly attenuates CHPG-induced Ca 2 signals (n  4 – 8 animals per group). *p  0.05; **p  0.02; ***p  0.01. Error bars indicate SEM.
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(Figs. 2, 3) that cause glial glutamate release, which in turn
stimulates NMDA receptor-dependent SICs in cortical pyra-
midal neurons (Fig. 4).
Because of the potential for astrocytic and synaptic glutamate
to access distinct NMDA receptors (Fellin et al., 2004), we deter-
mined the relative sensitivity of SICs and intracortical evoked
EPSCs to NVP-AAM077 (0.4 M) and ifenprodil (3 M), which
preferentially inhibits NR2A/C/D- and NR2B-containing
NMDA receptors, respectively (Williams, 1993; Auberson et al.,
2002; Neyton and Paoletti, 2006). The amplitude of SICs was
reversibly reduced by ifenprodil ( p  0.01), whereas they were
insensitive to NVP-AAM077 (Fig. 4E,F). In contrast, intracorti-
cal NMDA receptor-mediated EPSCs were reversibly attenuated
by NVP-AAM077 (Fig. 4H, I) ( p  0.01) but insensitive to ifen-
prodil (Fig. 4G,I). The selective attenuation of synaptic NMDA
receptors by NVP-AMM077 and attenuation of SICs by ifen-
prodil show that gliotransmission, which is mediated by SICs,
preferentially accesses extrasynaptic NR2B-containing NMDA
receptors. Because NR2A- but not NR2C- or NR2D-containing
NMDA receptors exhibit rapid kinetics (Vicini et al., 1998), it is
likely that the NVP-AAM077-sensitive synaptic NMDA currents
are mediated predominantly by NR2A-containing NMDA recep-
tors. Thus, astrocytic, but not synaptic, glutamate preferentially
accesses extrasynaptic NR2B subunit-containing NMDA
receptors.
Delayed neuronal death is suppressed by antagonists of
gliotransmission that do not affect synaptic transmission
Before evaluating the potential for astrocytes to contribute to
delayed neuronal death, we first confirmed that pilocarpine is
able to induce neuronally detected SICs as is predicted based on
the ability of status epilepticus to induce astrocytic Ca 2 signals.
Because it is not currently feasible to study SICs in vivo, we re-
corded from layer II/III cortical pyramidal neurons in brain slice
preparations and included pilocarpine (10 M) within reduced
Mg 2 picrotoxin-containing ACSF to induce prolonged SE-like
epileptiform events (Fig. 4 J). After pilocarpine-induced epilepti-
form activity, we added TTX (1 M) to block neuronal activity
and reveal SICs. Pilocarpine-induced epileptiform activity signif-
icantly increased SIC frequency (Fig. 4K) compared with precon-
trol basal levels. This increase in SIC frequency required epilep-
tiform activity because incubation in TTX along with initial
pilocarpine-ACSF to prevent epileptiform discharges failed to
significantly increase SIC frequency (Fig. 4K).
Given that SE in vivo evokes astrocytic Ca 2 signals,
pilocarpine-induced epileptiform activity in situ stimulates SICs,
and because glial glutamate activates NR2B subunit-containing
NMDA receptors (Fig. 4), an NMDA receptor pathway impli-
cated in mediating neuronal death (Hardingham et al., 2002), we
investigated the potential for a linkage between gliotransmission
and the delayed cell death that is known to follow SE (Borges et
al., 2003). First, we confirmed the relative selectivity of pharma-
cological agents by monitoring astrocytic Ca 2 signals and
whisker-deflection evoked potentials. In agreement with acute
administration of MPEP (Fig. 3), daily intraperitoneal adminis-
tration of MPEP (20 mg/kg), which commenced immediately
after the termination of SE, reduced astrocytic Ca 2 signals (n 
4 animals; p  0.0025) (Fig. 3C). In contrast, administration of
MPEP had no impact on whisker-evoked potentials (supplemen-
tal Fig. 2A,D, available at www.jneurosci.org as supplemental
material) (n  4 animals) nor on intracortical synaptic transmis-
sion (supplemental Fig. 1E,G, available at www.jneurosci.org as
supplemental material). Ca 2-dependent astrocytic glutamate
acts on extrasynaptic NR2B-containing NMDA receptors (Fig.
4). Accordingly, acute cortical administration of ifenprodil (20
M), an NR2B-selective antagonist, neither affected the whisker-
evoked potentials (supplemental Fig. 2B,D, available at www.
jneurosci.org as supplemental material) (n  3 animals) nor as-
trocytic Ca 2 signals (Figs. 2C, 3C) (n  3– 4 animals), whereas
as a positive control for drug access, TTX (1 M) blocked evoked
potentials (supplemental Fig. 2C,D, available at www.
jneurosci.org as supplemental material) (n  3 animals; p 
0.0002). Thus, MPEP and ifenprodil can be used selectively to
prevent astrocytic Ca 2 signals and to attenuate astrocyte-
evoked SICs without significant actions on either synaptic
NMDAR currents or on whisker-evoked synaptic potentials and
neuron-based integration.
We determined the time course of neuronal death that follows
SE by labeling sections from animals with FJB (Schmued and
Hopkins, 2000), a fluorescent label that selectively identifies dy-
ing cells. After SE, FJB-labeled neurons, which colabel with the
neuronal marker NeuN, were observed in layer 2/3 of the cortex
(Fabene et al., 2003) (Fig. 5A,B), the same cortical region in
which in vivo imaging and slice electrophysiology was performed.
The peak of FJB-labeled neurons correlated with the period of
astrocytic Ca 2 signals with labeling declining thereafter (Fig.
5C). Because of this temporal correlation, we determined the
relative roles for gliotransmission and synaptic transmission in
mediating this neuronal death. One hour after the cessation of SE,
we commenced four daily intraperitoneal injections of MPEP (20
mg/kg, i.p.), ifenprodil (20 mg/kg, i.p.), MK801 (1 mg/kg, i.p.),
NVP-AAM077 (2 mg/kg, i.p.), or vehicle. Administration of if-
enprodil (n  4 animals) or MPEP (n  4 animals), antagonists
that attenuate gliotransmission but have no actions on NMDAR-
mediated synaptic transmission or whisker-evoked field poten-
tials, both caused significant neuronal protection (Fig. 5D,E)
(ifenprodil, p  0.01; MPEP, p  0.05). In contrast, NVP-
Figure 3. Astrocytic Ca 2 signals in vivo in mice 3 d after SE are suppressed by the mGluR5
antagonist MPEP. A, Fluo-4-labeled astrocytes before (left) and after (right) the mouse was
coinjected with MPEP and rhodamine-dextran through the tail vein. B, Calcium signals of a cell
pair were inhibited after MPEP injection. C, Calcium signals before and after acute administra-
tion of MPEP (1 mg/kg tail vein injection), depicted as the F/F0 integral. Also shown is the
inhibition by four daily intraperitoneal administrations of MPEP (20 mg/kg). The NR2B NMDA
receptor antagonist ifenprodil (20 M) does not affect astrocytic Ca 2 signals. *p  0.002
(n  4 animals in each group except ifenprodil, n  3). Error bars indicate SEM.
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AAM077, which attenuates NMDAR-mediated synaptic trans-
mission but not gliotransmission, did not provide neuronal pro-
tection (Fig. 5D,E). MK801, a use-dependent NMDAR
antagonist that does not select between NR2B- or NR2A-
containing NMDA receptor subunits offered intermediate pro-
tection compared with ifenprodil and NVP-AAM077. As an al-
ternative approach to FJB labeling, we waited for 7 d after SE and
identified and counted NeuN-positive neuronal cell bodies. Sim-
Figure 4. Gliotransmission but not intracortical synaptic transmission activates the NR2B-containing NMDA receptors of layer 2–3 pyramidal neurons. A, Whole-cell recording from a pyramidal
neuron showing SICs induced by bath application of CHPG (0.5 mM). In these as well as in B–F, experiments are performed in the continuous presence of TTX (1 M). B, Left, Percentage of neurons
showing increased SIC frequency after application of DHPG (10 –20 M; 4 of 11 cells), CHPG (0.5–1 mM; 7 of 20), and CHPG and MPEP (0.5–1 mM and 50 M, respectively; 1 of 17). In the latter
experiments, the slice was preincubated with MPEP for 5 min before the application of CHPG and MPEP. The ability of MPEP to block actions of CHPG was tested using Fisher’s exact test ( p  0.05).
Right, Average frequency of SICs before and after DHPG (n  4) and CHPG (n  7) in the responsive neurons shown in the left panel. In this as well as in the other panels of this figure, *p  0.05
and **p  0.01. Error bars indicate SEM. C, Whole-cell recording from a pyramidal neuron showing SICs induced by photolysis of caged Ca 2 in single cortical astrocytes. D, Average frequency of
SICs under control conditions, in the presence of D-AP5 (50 M), and after D-AP5 washout in six cortical neurons showing SIC activity. SICs were stimulated by application of CHPG (0.5–1 mM) or low
Ca 2 containing ACSF. E, F, Mean amplitude of SICs under control conditions, in the presence of ifenprodil (E; 3 M) or NVP-AAM077 (F; 0.4 M), and after drug washout. Data are normalized to
the amplitude of SICs recorded under control conditions. See inset for representative SICs from the same cell under the different experimental conditions. Number of averaged SICs is 37, 48, and 70
from 9 cells for E, and 27, 25, and 13 from 7 cells for F, respectively. G, H, Representative experiments showing the time course of the NMDA EPSC-amplitude at basal condition (0 Mg 2-containing
saline in the presence of 10 M NBQX), during ifenprodil (G; 3 M) and NVP-AAM077 (H; 0.4 M) application, and after drug washout. Subsequent application of D-AP5 (50 M) completely blocked
the EPSC (data not shown). Inset, Average of 10 EPSCs in the different experimental conditions. EPSCs were evoked by positioning the stimulating electrode intracortically, 100 –200 m from the
recording pipette. I, Ifenprodil (left; 3 M) does not decrease the average amplitude of the NMDA EPSC (n  6 cells), whereas NVP-AAM077 (right; 0.4 M) drastically reduces its amplitude (n 
4 cells). Data are normalized to the average NMDA EPSC amplitude under control conditions. J, Epileptiform activity induced by acute application of pilocarpine (10 M) triggers an increase in SIC
frequency. Representative experiment showing membrane current under basal conditions (left), in the presence of pilocarpine (middle), and in the presence of pilocarpine and TTX (1 M; right).
Addition of TTX blocks pilocarpine-induced epileptiform activity and reveals the presence of SICs. Pilocarpine was always applied in the presence of 0 Mg 2 and 100 M picrotoxin (see Materials and
Methods). During epileptiform activity, unclamped action potentials were recorded and have been truncated for presentation purposes. K, Average SIC frequency under basal conditions in normal
ACSF before perfusion of pilocarpine (left; open bar). After epileptiform activity was triggered by application of pilocarpine, 1 M TTX was added to the saline to block neuronal activity. Thereafter,
SIC frequency was measured again in 6 of 10 layer 2/3 neurons displaying SICs (left; filled bar). When TTX was added together with pilocarpine, no epileptiform activity was initiated in the slice and
no significant increase in SIC frequency was observed in four of seven neurons displaying SICs (right).
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ilar to the FJB data, ifenprodil (n  4 animals; p  0.05) and
MPEP (n  4 animals; p  0.05), but not NVP-AAM077 (n  3
animals), afforded significant protection against delayed neuro-
nal death that normally follows SE (Fig. 5F). In agreement with
these results in the cortex, we found a similar pattern of hip-
pocampal pyramidal neuron protection by antagonists that at-
tenuate gliotransmission (supplemental Fig. 3, available at www.
jneurosci.org as supplemental material).
Neuronal protection afforded by attenuation of astrocytic
Ca 2 signals
Although pharmacological evidence supports the hypothesis that
gliotransmission contributes to delayed neuronal death, we
sought alternative experimental strategies to selectively target the
astrocyte. Because application of acetoxymethyl esters of Ca 2
indicators to the cortical surface selectively labels astrocytes
(Nimmerjahn et al., 2004; Takano et al., 2006), we used this ap-
proach to attenuate astrocytic Ca 2 signaling and thus Ca 2-
dependent gliotransmission. To evaluate the feasibility of the ap-
proach, we first loaded neurons and astrocytes with Ca 2
indicator using the bulk-loading technique (Stosiek et al., 2003)
by ejecting fluo-4 AM from the tip of a pipette into layer 2/3 of the
cortex. Subsequently, we applied BAPTA-AM together with the
astrocyte selective dye SR101 to the cortical surface to load these
compounds into astrocytes only. Figure 6A shows fluo-4-labeled
neurons (green) and astrocytes (yellow) together with Ca 2 sig-
nals recorded in these cells (Fig. 6B). Surface application of
BAPTA-AM had no impact on neuronal Ca 2 signals (Fig.
6B,C), as expected if surface application of this Ca 2 chelator led
to selective loading into astrocytes. We then stimulated 1-(6-
[(17-methoxyestra-1,3,5[10]-trien-17-yl)amino]hexyl)-1H-
pyrrole-2,5-dione (U73122) (10 M)-sensitive phospholipase
C-dependent astrocytic Ca 2 signals by application of ATP (0.5
mM) to the cortex. ATP-induced Ca 2 signals were significantly
reduced by previous surface application of BAPTA-AM ( p 
0.001). Because surface application of BAPTA-AM selectively at-
tenuated astrocytic Ca 2 signals, we used this approach to deter-
mine whether astrocytic Ca 2 signals contribute to delayed neu-
ronal death after SE.
To determine whether SE-induced astrocytic Ca 2 signals in-
duce neuronal death, we injected mice with pilocarpine, and then
1 h later terminated SE with diazepam. Subsequently, we made a
unilateral craniotomy through which we locally applied BAPTA-
AM, or vehicle, to the cortical surface. Three days later, animals
were cardiac perfused, sectioned, and labeled with FJB to count
dying neurons. Selective loading of BAPTA into astrocytes re-
duced FJB labeling ipsilateral but not contralateral to the crani-
otomy (Fig. 6 I, J). In parallel control mice, we applied the carrier
to the cortex and found that FJB labeling was not significantly
different from the contralateral unoperated cortex. Because Ca 2
indicators bind Ca 2, increase the Ca 2 buffering capacity of a
cell, and thereby attenuate Ca 2 signals, we asked whether appli-
cation of fluo-4 AM to the cortical surface, and the resulting
selective labeling of astrocytes (supplemental Fig. 4, available at
www.jneurosci.org as supplemental material), would be neuro-
protective. Similar to experiments performed with BAPTA-AM,
we found that the loading of fluo-4 selectively into astrocytes after
SE, did afford significant unilateral protection as assessed by FJB
labeling (Fig. 6 J).
Discussion
We provide the first evidence supporting the concept that the
release of the gliotransmitter glutamate from astrocytes can pro-
vide a stimulus that induces the delayed neuronal death. This
conclusion is based on a sequence of experimental evidence: SE
induces astrocytic Ca 2 signals that persist for 3 d (Fig. 1) and
that are temporally correlated with the period of delayed neuro-
nal death (Fig. 5C). Ca 2-stimulated glutamate-dependent glio-
transmission acts selectively on extrasynaptic NR2B-containing
NMDA receptors (Fig. 4), and ifenprodil, an NR2B selective an-
tagonist, provides almost complete neuronal protection from de-
layed death (Fig. 5; supplemental Fig. 3, available at www.
jneurosci.org as supplemental material). In contrast, NVP-
AAM077, an antagonist of NR2A-containing NMDA receptors,
which attenuates layer 2/3 synaptic NMDA currents, does not
afford neuronal protection after SE. Although neuronal protec-
tion provided by ifenprodil is consistent with astrocytes stimulat-
ing neuronal death through the NR2B-containing NMDA recep-
tor, it is also possible that enhanced synaptic activity resulting
from SE leads to transmitter spillover allowing synaptic gluta-
Figure 5. MPEP and ifenprodil protect neurons from SE-evoked death. FJB-stained sections
of murine cortex from control (A) and mice 3 d after SE (B) show FJB labeling in layer 2/3, the
region in which in vivo imaging and slice electrophysiology were performed. C, Time course of
FJB labeling. D, The region identified by the dashed lines in B is shown from animals treated
with glutamate receptor antagonists, as labeled. E, MPEP (20 mg/kg), ifenprodil (20 mg/kg),
and MK-801 (1 mg/kg) significantly reduce the number of FJB-labeled cells 3 d after SE, whereas
NVP-AAM077 (2 mg/kg) is not protective. F, In parallel experiments, the number of NeuN-
labeled neurons in cortical layers 2/3 7 d after SE were counted using an automated system.
Similar to results obtained with FJB, MPEP and ifenprodil, but not NVP-AAM077, protected
neurons from delayed death that normally follows SE. *p  0.05; **p  0.01; n  4 –7
animals in each condition. Error bars indicate SEM.
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mate to access extrasynaptic receptors
(Scimemi et al., 2004). In support of a glio-
transmission origin of NR2B-mediated
neuronal death is our observation of neu-
ronal protection provided by the mGluR5
antagonist MPEP, which attenuates astro-
cytic Ca 2 signaling (Fig. 3B,C) and thus
gliotransmission while not impacting syn-
aptic transmission (supplemental Fig. 1,
available at www.jneurosci.org as supple-
mental material). Undoubtedly, ifenprodil
and MPEP could affect neuron-based sig-
nals and they could affect receptors in ad-
dition to NR2B and mGluR5. However,
neither intracortical synaptic transmission
(Fig. 4G,I; supplemental Fig. 1E, available
at www.jneurosci.org as supplemental ma-
terial) nor evoked potentials recorded in
vivo were inhibited by these drugs (supple-
mental Fig. 2, available at www.jneuro-
sci.org as supplemental material). Regard-
less of such specificity issues, it is
important to note that they reduce glio-
transmission and are neuroprotective.
This correlation provides a foundation to
propose that astrocytes contribute to de-
layed neuronal death. To test this possibil-
ity, we used a cell type selective manipula-
tion that attenuates astrocytic Ca 2
signals. Topical application of AM-
conjugated BAPTA-based compounds to
the cortical surface led to selective labeling
of astrocytes (Hirase et al., 2004; Nimmer-
jahn et al., 2004; Gobel et al., 2007). Astro-
cytes located hundreds of micrometers be-
neath the cortical surface label with these
compounds (supplemental Fig. 4, avail-
able at www.jneurosci.org as supplemental
material). This labeling is thought to result
from the loading of astrocytes adjacent to
the cortical surface followed by dye trans-
fer to adjacent astrocytes through gap
junctions (Nimmerjahn et al., 2004). Im-
aging confirmed the selectivity of labeling
because only astrocytic Ca 2 signals were
attenuated by BAPTA. We went on to show that attenuation of
astrocytic Ca 2 signals is neuroprotective. It should be noted
that, in addition to BAPTA, the Ca 2 indicator fluo-4 was also
neuroprotective. Although this might seem surprising, it must be
remembered that fluo-4 is a fluorescent BAPTA derivative that
binds Ca 2 with a similar affinity (345 nM) to BAPTA (160 nM).
When taken together with the pharmacological evidence that
MPEP and ifenprodil are neuroprotective, we suggest that SE
evokes Ca 2 signals causing the release of gliotransmitters and
the activation of NR2B-containing NMDA receptors that stimu-
late the cell death cascade and lead to the progressive loss of
neurons. Because astrocytic Ca 2 signals induce the release of
D-serine as well as glutamate, we cannot exclude the possibility
that this coagonist of the NMDAR also contributes to neuronal
excitotoxicity.
This and several previous studies have shown that neuronally
detected SICs are evoked by astrocytes and in response to eleva-
tions in their internal Ca 2. In cultures, SICs require astrocytic
Ca 2 elevations and are prevented by the loading of BAPTA into
astrocytes (Araque et al., 1998). The photolytic release of Ca 2 in
astrocytes evokes short latency (	10 ms) NMDA receptor-
dependent SICs in cocultured neurons (Parpura and Haydon,
2000). In brain slices, stimuli that elevate astrocytic Ca 2, such as
ATP and mGluR5 agonists, cause a correlated increase in SIC
frequency that is unaffected by acute application of tetanus neu-
rotoxin holoprotein (Fellin et al., 2004) at a time when synaptic
transmission, but not gliotransmission, is blocked, demonstrat-
ing their non-neuronal origin. In slice preparations, photolytic
elevation of astrocytic Ca 2 causes NMDAR-dependent SICs
(Fig. 4C) that are evoked when the Ca 2 signal propagating
within the astrocytic processes arrives at the location of the neu-
ronal dendrite (Fellin et al., 2004; D’Ascenzo et al., 2007). Addi-
tional support for an astrocytic origin is provided by the obser-
vation that intracellular dialysis of IP3 into single astrocytes
evokes SICs in adjacent neurons (Kang et al., 2005). Because SICs
have been observed in many brain regions including areas CA1
Figure 6. Attenuation of astrocytic Ca 2 signals by loading of Ca 2 chelators is neuroprotective. A, Two-photon overlay
image (fluo-4, green; SR101, red; colocalization, yellow) of layer 2/3 neurons loaded with fluo-4 and astrocytes loaded with fluo-4
and SR101. Fluo-4 AM was injected into the cortex using the bulk-loading approach to label neurons and astrocytes, whereas
SR101 was applied to the surface of the cortex to selectively label astrocytes. With neurons and astrocytes coloaded with fluo-4,
BAPTA-AM was applied to the cortical surface to selectively load into astrocytes. Selectivity of loading was confirmed by monitor-
ing neuronal and astrocytic Ca 2 signals. B, Spontaneous neuronal Ca 2 signals in control and BAPTA-loaded animals. C, Surface
application of BAPTA-AM does not reduce neuronal Ca 2 signals. D–F, Application of ATP (0.5 mM; n  4) to the cortex evokes
robust Ca 2 signals in astrocytes (E), which are attenuated by previous application of BAPTA-AM to the cortical surface (n  5;
compare E, F ). G, The phospholipase C inhibitor U73122 (10 M; n  4) attenuates ATP-induced Ca 2 signals, providing
additional support for an astrocytic origin of these Ca 2 signals. H, Summary of ATP-induced Ca 2 signals. I, After status
epilepticus, BAPTA-AM was applied to the cortical surface through a craniotomy to selectively attenuate astrocytic Ca 2 signals,
and 3 d later, Fluoro-Jade B labeling of dying neurons was assessed both ipsilateral (BAPTA) and contralateral to the treatment. J,
The selective loading of the Ca 2 chelator BAPTA into astrocytes resulted in fewer dying, FJB-labeled cells compared with
contralateral untreated cortex (paired t test). Surface loading with the fluorescent Ca 2 indicator, fluo-4, caused similar neuro-
protection, whereas application of vehicle did not. *p  0.05; **p  0.01; ***p  0.001. Error bars indicate SEM.
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and CA3 of the hippocampus (Angulo et al., 2004; Fellin et al.,
2004; Kang et al., 2005; Perea and Araque, 2005; Tian et al., 2005),
the thalamus (Parri et al., 2001), the olfactory bulb (Kozlov et al.,
2006), the nucleus accumbens (D’Ascenzo et al., 2007), and the
cortex (this study), it is likely that they are a general property of
the nervous system.
In this study, we found distinct pharmacological sensitivity of
NMDA receptors mediating synaptic transmission and gliotrans-
mission. It is unlikely, however, that all synapses preferentially
use NR2A- rather than NR2B-containing NMDA receptors. For
example, in the hippocampus pharmacological studies have sup-
ported a role for NR2B-containing synaptic NMDA receptors
(Kawakami et al., 2003; Scimemi et al., 2004). In a previous study
in the rat cortex, NR2A-containing NMDA receptors were shown
to mediate colossal– cortical synaptic transmission, whereas in-
tracortical synapses made onto the same postsynaptic neurons
were mediated by NR2B-containing NMDA receptors (Kumar
and Huguenard, 2003). We found that intracortical synaptic
NMDA receptors contained NR2A subunits. These differences
may be because our studies were performed with older animals
(up to postnatal day 48 compared with 21), in mice rather than in
rats, and because we recorded from layer 2/3 rather than layer 5
pyramidal neurons (Kumar and Huguenard, 2003). Regardless of
the subunit composition of synaptic NMDA receptors, of impor-
tance for this study is the observation that gliotransmission is
suppressed by the NR2B antagonist ifenprodil, which is neuro-
protective, providing one of several lines of evidence in support
of a role for gliotransmission in neuronal excitotoxicity.
Because acute application of the mGluR5 agonist CHPG in-
duces cell-wide Ca 2 signals and Ca 2 waves between cortical
astrocytes of control mice (Fig. 2) with similar properties to those
seen after SE (Fig. 1), we anticipate that after SE a rise in extracel-
lular glutamate levels, perhaps resulting from immediate conse-
quence of cellular damage during the seizure itself, induces the
enhanced Ca 2 signaling of astrocytes. In turn, these signals lead
to glutamate release and gliotransmission, which activates NR2B-
containing NMDA receptors and initiates the cell death response.
An alternative is the possibility of a role for neurons in a positive-
feedback loop in which neuronal activity leads to mGluR5-
dependent Ca 2 signals in astrocytes, which in turn leads to the
release of the gliotransmitter glutamate that in return excites neu-
rons through NMDA receptor function.
Our observation of enhanced astrocytic Ca 2 signaling in vivo
after SE supports a previous cell culture study that investigated
Ca 2 signaling in astrocytes isolated from a patient with Rasmus-
sen’s encephalitis, a rare form of intractable epilepsy. In that
study, the tissue was isolated during surgery, and then plated into
primary culture, and astrocytic Ca 2 signals were monitored
thereafter. Initially, spontaneous Ca 2 signals were present, al-
though their frequency declined during the following weeks
(Manning and Sontheimer, 1997). Although control tissue was
not available to make comparison measurements, taking these
observations together with those presented in our study raises the
potential of a general principle of glial Ca 2 signaling in which
seizures enhance the Ca 2 excitability of astrocytes for prolonged
periods that outlast the duration of the seizure itself.
Our demonstration that gliotransmission selectively activates
NR2B-containing NMDA receptors, that these receptors are ex-
trasynaptic and synaptic glutamate acts via NR2A-containing
NMDA receptors suggests the potential for a general role for
astrocytes in neuronal degeneration. Perhaps NR2B subunit-
dependent neuronal degeneration in models of traumatic brain
injury (Deridder et al., 2005) and Huntington’s disease (Zeron et
al., 2002) and during ischemic injury (Gao et al., 2005) is medi-
ated by the release of glutamate from astrocytes. This role of
NR2B subunit-containing NMDA receptors in mediating neuro-
nal death together with the selective activation of these receptors
by gliotransmission raises the potential of the astrocyte to con-
tribute to neurodegeneration, especially because it is known that
these glial cells become reactive during many neurological con-
ditions including Alzheimer’s and Parkinson’s disease as well as
during epilepsy (Miller, 2005).
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